0.0605
+0.0105
+(21.00%)
At close: April 17 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
18,502
18,502
27,837
44,335
115,796
Operating Income
-18,502
-18,502
-27,837
-44,335
-115,796
Net Non Operating Interest Income Expense
-186
-186
374
249
-18
Other Income Expense
-6,438
-6,438
-2,687
4,332
22,751
Pretax Income
-25,126
-25,126
-30,150
-39,754
-93,063
Net Income Common Stockholders
-25,126
-25,126
-30,159
-39,754
-348,885
Diluted NI Available to Com Stockholders
-25,126
-25,126
-30,159
-39,754
-348,885
Total Operating Income as Reported
-18,502
-18,502
-27,837
-44,335
-115,796
Total Expenses
18,502
18,502
27,837
44,335
115,796
Net Income from Continuing & Discontinued Operation
-25,126
-25,126
-30,150
-39,754
-93,063
Normalized Income
-23,469
-23,469
-30,170
-44,591
-115,814
Interest Income
44
44
494
249
--
Interest Expense
230
230
120
--
18
Net Interest Income
-186
-186
374
249
-18
EBIT
-24,896
-24,896
-30,030
-39,754
-93,045
EBITDA
-24,891
-24,891
-30,025
-39,750
-93,043
Reconciled Depreciation
5
5
5
4
2
Net Income from Continuing Operation Net Minority Interest
-25,126
-25,126
-30,150
-39,754
-93,063
Total Unusual Items Excluding Goodwill
-1,657
-1,657
20
4,837
22,751
Total Unusual Items
-1,657
-1,657
20
4,837
22,751
Normalized EBITDA
-23,234
-23,234
-30,045
-44,587
-115,794
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIOS.BR BioSenic S.A.
0.0018
0.00%
AGNPF Algernon Pharmaceuticals Inc.
0.0600
0.00%
VXL.V Vaxil Bio Ltd.
0.0100
0.00%
NRX.V NurExone Biologic Inc.
0.6900
0.00%
RLFTF Relief Therapeutics Holding SA
3.0600
-1.29%
VANI Vivani Medical, Inc.
1.0600
+0.95%
TSOI Therapeutic Solutions International, Inc.
0.0003
+50.00%
NRSN NeuroSense Therapeutics Ltd.
1.0333
-0.64%
SILO Silo Pharma, Inc.
1.0748
+4.35%
SEER Seer, Inc.
1.9700
-0.51%